DCGO · DocGo Inc.

NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD

DocGo Inc (DCGO)

NASDAQ NMS - GLOBAL MARKET Health Care
Move probability → Options chain →
$0.26 +0.01 (+2.32%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE $0.26
$0.26 $0.26
52-WEEK RANGE $0.26
$0.24 $1.65

What's happening

Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.

Key Statistics

Market Cap$26.5M
P/E (TTM1)—
EPS2 (TTM)$-1.96
Div Yield—
Beta30.97
Volume3,052
Open0.26
Prev Close0.26
Bid / Ask0.22 / 0.30
Next Earnings 2026-11-09 (after market close)

Analyst Recommendations

Strong buy 3 Buy 4 Hold 4 Sell 0 Strong sell 0

Aggregate ratings for 2026-10-01 (11 analysts polled by Finnhub) — consensus count.

Performance Overview (Trailing returns vs S&P 500 benchmark)

YTD RETURN
DCGO -70.49%
vs S&P 500 -83.27%
1-YEAR RETURN
DCGO -78.41%
vs S&P 500 -92.97%
6-MONTH RETURN
DCGO -55.71%
3-MONTH RETURN
DCGO -59.69%

Valuation Measures & Ratios

Enterprise Value4$16.5M
Forward P/E5—
PEG Ratio6-0.00
Price / Sales (TTM1)0.09
Price / Book70.43
EV4 / Revenue0.06
EV4 / EBITDA2.76
Profit Margin-65.29%
Operating Margin-62.26%
Return on Equity (ROE8)-115.58%
Return on Assets (ROA9)-79.60%
Avg Volume (3M)845,280
Quarterly history (5 periods)
Measure Jun '26Mar '26Sep '25Jun '25Mar '25
Market cap $51.4M $61.5M $135.4M $158.2M $275.9M
P/E -0.74 -0.97 -3.16 -18.54 19.92
Price/Sales 0.17 0.19 0.35 0.33 0.47
Price/Book 0.43 0.46 0.50 0.53 0.89
EV/Revenue 0.09 0.08 0.16 0.11 0.33
EV/EBITDA -0.32 -0.33 -1.31 — —
ROE -58.38% -47.68% -15.83% -2.87% 4.48%
ROA -37.21% -30.15% -12.11% -2.09% 3.21%

Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).

Glossary — what these abbreviations mean
1. TTM
Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
2. EPS
Earnings per share — net income divided by diluted shares outstanding.
3. Beta
A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
4. EV (Enterprise Value)
Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
5. Forward P/E
Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
6. PEG Ratio
P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
7. Price / Book
Share price divided by book value (assets minus liabilities) per share.
8. ROE
Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
9. ROA
Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
10. MRQ
Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
11. YoY
Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.

Short Interest

Shares Short1,993,731
Change from Prior Settlement-27.87%
% of Float—
Days to Cover (Short Ratio)2.63

Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.

Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.

Price history

Events

Drag horizontally to zoom into a section; use Reset view to restore all observations.

Technical signal summary

Calculating from the latest year of daily price history…

Calculating…
Show Technical Analysis Breakdown ▾ 10 Indicators

Not investment advice — read several signals together.

Indicators None active

Add lines over the price chart or a panel below it. Your choices are saved on this device.

Starter sets
Trend
Oscillators
Volume/volatility
Loading chart…

History limited by data provider; markers are heuristics, not signals.

Peer and sector context

No reviewed peer group is available for this symbol.

Balanced evidence

A deterministic summary of sourced facts—not an AI verdict.

Potential strengths

  • Latest SEC filing is Form 8-K, filed 2026-10-05; review it for current changes and risks. SEC EDGAR ↗

Potential concerns

Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.

Financials

Income statement

Line item Jun '26Mar '26Sep '25Jun '25Mar '25Sep '24Jun '24Mar '24
Revenue $73.4M $75.6M $70.8M $80.4M $96.0M $138.7M $164.9M $192.1M
Operating income -$17.9M -$18.7M -$42.0M -$17.5M -$14.0M $10.1M $10.1M $15.9M
Net income -$15.8M -$14.8M -$27.8M -$11.2M -$9.4M $5.5M $6.5M $11.2M
EPS (diluted) $-0.16 $-0.15 $-0.28 $-0.11 $-0.09 $0.05 $0.06 $0.10
EPS (basic) $-0.16 $-0.15 $-0.28 $-0.11 $-0.09 $0.05 $0.06 $0.11
Operating margin -$24 -$25 -$59 -$22 -$15 $7 $6 $8

Balance sheet

Line item Jun '26Mar '26Dec '25Dec '25Sep '25Jun '25Mar '25Dec '24
Total assets $186.8M $209.2M $217.1M — $353.8M $408.3M $430.8M $455.6M
Total liabilities $91.0M $98.0M $91.2M — $93.1M $120.5M $128.9M $140.4M
Stockholders' equity $119.1M $132.3M $144.0M — $270.5M $297.3M $309.3M $320.9M
Total current assets $119.8M $138.2M $152.4M — $190.2M $236.6M $262.5M $304.5M
Total current liabilities $72.3M $77.2M $67.5M — $73.6M $100.1M $107.6M $121.8M
Cash & equivalents $25.2M $35.7M $51.0M — $73.4M $104.2M $79.0M $89.2M

Cash flow

Line item Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24
Operating cash flow -$9.2M -$4.7M -$10.5M $1.7M $34.0M $9.2M $12.7M $31.1M
Investing cash flow -$3.9M $1.7M -$13.1M $1.1M -$21.8M -$5.3M -$5.4M -$1.6M
Financing cash flow -$1.7M -$2.5M -$1.9M -$33.1M -$7.4M -$8.5M -$7.9M -$7.4M
Free cash flow -$9.6M -$5.1M -$12.0M $782.6K $32.9M $8.2M $12.0M $30.2M
Capital expenditures $320.8K $430.3K $1.5M $876.2K $1.1M $1.0M $724.8K $902.2K
Depreciation & amortization $2.7M $2.6M $11.9M $4.0M $4.0M $3.8M $11.7M $4.2M

Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.

Institutional holders

SEC Form 13F filers holding DCGO as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.

Institutional ownership is not available for this symbol right now.

Insider activity

Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.

Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2025-03-07 to 2026-05-12

Recent transactions

  • Most recent: Bienstock Lee (Chief Executive Officer) — Tax withholding of 15,644 shares on 2026-05-12.

Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.

Insider purchases & sales, last 6 months

Purchases (open market)0 sh(0 txns)
Sales (open market)0 sh(0 txns)
Net Shares+0

Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.

Insider roster

NameTitleMost Recent TransactionDateShares
Bienstock LeeChief Executive OfficerTax withholding2026-05-1215,644
ROSENBERG NORMANCFO and TreasurerTax withholding2025-12-1565,774
Sugrue StephenChief Compliance OfficerTax withholding2025-12-1535,968
Tendler Ely DGeneral Counsel and SecretaryOpen market sale2025-12-1516,850
Burdiek Michael JDirectorGrant / award2025-12-12150,000
Leite EtalvinaDirectorGrant / award2025-12-12150,000
Smedra IraDirectorGrant / award2025-12-12150,000
TRAVERS JAMES MDirectorGrant / award2025-12-12150,000
Klasko Stephen K. M.D.DirectorGrant / award2025-09-10100,000

Recent transactions

DateInsiderTitleTransactionSharesPrice
2026-05-12Bienstock LeeChief Executive OfficerTax withholding 15,644$0.59
2026-03-30Bienstock LeeChief Executive OfficerTax withholding 18,811$0.57
2025-12-15Bienstock LeeChief Executive OfficerTax withholding 214,131$0.91
2025-12-15ROSENBERG NORMANCFO and TreasurerTax withholding 65,774$0.91
2025-12-15Sugrue StephenChief Compliance OfficerTax withholding 35,968$0.91
2025-12-15Tendler Ely DGeneral Counsel and SecretaryOpen market sale 16,850$0.91
2025-12-12Bienstock LeeChief Executive OfficerGrant / award 1,113,495$0.00
2025-12-12ROSENBERG NORMANCFO and TreasurerGrant / award 429,405$0.00
2025-12-12Sugrue StephenChief Compliance OfficerGrant / award 321,055$0.00
2025-12-12Tendler Ely DGeneral Counsel and SecretaryGrant / award 100,000$0.00
2025-12-12Burdiek Michael JDirectorGrant / award 150,000$0.00
2025-12-12Leite EtalvinaDirectorGrant / award 150,000$0.00
2025-12-12Smedra IraDirectorGrant / award 150,000$0.00
2025-12-12TRAVERS JAMES MDirectorGrant / award 150,000$0.00
2025-09-10Klasko Stephen K. M.D.DirectorGrant / award 100,000$0.00
2025-07-02Sugrue StephenChief Compliance OfficerTax withholding 5,813$1.52
2025-07-02ROSENBERG NORMANCFO and TreasurerTax withholding 11,332$1.52
2025-07-02Bienstock LeeChief Executive OfficerTax withholding 18,597$1.52
2025-05-23Burdiek Michael JDirectorOpen market purchase 10,000$1.33
2025-05-15Burdiek Michael JDirectorOpen market purchase 15,000$1.43
2025-05-14Klasko Stephen K. M.D.DirectorOpen market purchase 15,000$1.49
2025-05-14Sugrue StephenChief Compliance OfficerOpen market purchase 10,000$1.44
2025-05-14ROSENBERG NORMANCFO and TreasurerOpen market purchase 15,000$1.47
2025-05-14Bienstock LeeChief Executive OfficerOpen market purchase 15,000$1.54
2025-05-13Bienstock LeeChief Executive OfficerTax withholding 15,565$1.44
2025-04-02Sugrue StephenChief Compliance OfficerTax withholding 5,614$2.68
2025-04-02ROSENBERG NORMANCFO and TreasurerTax withholding 8,004$2.68
2025-04-02Bienstock LeeChief Executive OfficerTax withholding 18,598$2.68
2025-03-31Bienstock LeeChief Executive OfficerTax withholding 18,742$2.64
2025-03-07Sugrue StephenChief Compliance OfficerGrant / award 77,520$0.00
2025-03-07Sugrue StephenChief Compliance OfficerTax withholding 7,789$3.03

Recent SEC filings

Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.

Source: SEC EDGAR submissions · updated 2026-10-21 22:43 UTC

FiledFormReport periodOfficial filing
2026-10-058-K2026-10-01 View on SEC.gov →
2026-08-1710-Q2026-06-30 View on SEC.gov →
2026-08-178-K2026-08-16 View on SEC.gov →
2026-07-318-K2026-07-28 View on SEC.gov →
2026-07-028-K2026-06-26 View on SEC.gov →
2026-06-188-K2026-06-16 View on SEC.gov →
2026-05-1442026-05-12 View on SEC.gov →
2026-05-1110-Q2026-03-31 View on SEC.gov →
2026-05-118-K2026-05-11 View on SEC.gov →
2026-04-228-K2026-04-17 View on SEC.gov →
2026-03-3142026-03-30 View on SEC.gov →
2026-03-1610-K2025-12-31 View on SEC.gov →

Headlines about DCGO (DocGo Inc.). Links open the publisher — we don’t host full articles.

SEC filings ↓

← Back to the full dashboard · My watchlist